3,5,8-Trihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl 6-deoxy-alpha-L-mannopyranoside(CAS: 85571-15-9)

This compound must adhere to GHS (Global Harmonized System of Classification and Labelling of Chemicals) for classification and labeling. REACH regulations in the EU require registration, evaluation, authorization, and restriction of chemicals. FDA and EPA have specific requirements for the handling, storage, and disposal of this compound. Compliance with local and international regulations is essential for safe handling and use.

Several alternatives can be used in synthesis, including 3,5,8-trihydroxy-2-(3-hydroxyphenyl)-4-oxo-4H-chromen-7-yl 6-deoxy-alpha-L-mannopyranoside and 3,5,8-trihydroxy-2-(benzoyloxyphenyl)-4-oxo-4H-chromen-7-yl 6-deoxy-alpha-L-mannopyranoside. These compounds can serve as effective substitutes depending on the specific requirements of the synthesis.

The market and research trends for this compound are showing increasing interest in its potential applications in pharmaceuticals and natural products. Research is focusing on its antioxidant and anti-inflammatory properties, leading to potential developments in drug discovery and formulation. Additionally, the compound is gaining attention in cosmetics for its skin health benefits.

Waste containing this compound should be collected in appropriate containers, labeled properly, and disposed of according to local regulations. Incineration or professional waste disposal services are recommended. Proper precautions should be taken to prevent environmental contamination, and protective equipment should be used during handling. Compliance with environmental protection standards is crucial to ensure safe disposal.